Xibing Xu | Data Science | Best Researcher Award

Dr. Xibing Xu | Data Science | Best Researcher Award

Shenzhen Medical Academy of Research and Translation, China

Author Profiles

orcid

Scopus

Early Academic Pursuits ๐ŸŽ“

Dr. Xibing Xuโ€™s academic journey began with a solid foundation in biological sciences, leading to his Master’s degree from Shandong University in 2012. His Master’s thesis focused on the two-component signal transduction systems of Streptomyces hygroscopicus. This foundational research sparked his interest in bacterial biology and set the stage for his doctoral studies at Sichuan University. Dr. Xuโ€™s Ph.D. thesis, completed in 2015, centered on โ€œProtein homeostasis regulation and ubiquitin-like systems in bacteria,โ€ deepening his expertise in bacterial systems and protein regulation.

Professional Endeavors ๐Ÿ’ผ

his Ph.D., Dr. Xu expanded his research horizons by embarking on various international and prestigious roles. In 2017-2018, he was awarded a visiting scholarship by the China Scholarship Council, enabling him to work as a visiting scholar at the Laboratoire de Microbiologie et Gรฉnรฉtique Molรฉculaire (LMGM) in Toulouse, France. This experience enhanced his research capabilities and fostered a deeper understanding of bacterial molecular mechanisms. From 2020 to the present, Dr. Xu has served as a Postdoctoral Fellow at LMGM, where he leads the ANR project M-Tox, which investigates translational control by HigB1 and MenT toxins in Mycobacterium tuberculosis.

Contributions and Research Focus ๐Ÿ”ฌ

Dr. Xuโ€™s research is at the cutting edge of microbiology, focusing on bacterial growth inhibition mechanisms mediated by toxins in toxin-antitoxin systems. Specifically, his work on deleterious tRNA nucleotidyltransferase toxins, like MenT in Mycobacterium tuberculosis, has unveiled novel bacterial mechanisms that regulate translation and protein homeostasis. His research involves exploring the role of tRNA biology in bacterial growth control and the interaction between tRNA and toxin proteins, a focus that has the potential to inform future therapeutic strategies for bacterial infections. His expertise extends to RNA-seq, enzymology, and protein-RNA/DNA interactions, all of which contribute to a deeper understanding of bacterial survival and virulence.

Impact and Influence ๐ŸŒ

Dr. Xuโ€™s work has far-reaching implications in microbial Microbiologie and therapeutic development. By identifying key mechanisms that control bacterial growth through toxin-antitoxin systems, his research addresses critical challenges in combating drug-resistant bacterial infections. His investigations into tRNA biology have provided insights into how bacteria regulate protein synthesis, which could lead to the development of novel antimicrobial strategies. His innovative research has garnered attention within the scientific community, reflected in invitations to present at major international conferences such as the 29th International tRNA Conference in 2024.

Academic Citations ๐Ÿ“š

Dr. Xuโ€™s contributions to the field have not only enhanced scientific knowledge but have also been widely recognized and cited in academic publications. His work on toxin-antitoxin systems and tRNA nucleotidyltransferase toxins has attracted significant attention in the microbiology and biochemistry fields. As his research continues to influence studies on bacterial translation control, his citation index is expected to grow, cementing his reputation as an expert in bacterial growth regulation and antibiotic resistance mechanisms.

Technical Skills ๐Ÿ› ๏ธ

Dr. Xu possesses a broad array of technical skills in biochemistry and molecular biology, enabling him to conduct complex experimental research. He is proficient in RNA-seq library design and construction, protein-DNA/RNA interaction analysis, and toxin protein purification and activity assays. Additionally, he has extensive experience in cell-free transcription and translation assays, essential for studying the mechanistic details of translation regulation in bacteria. His technical prowess underpins the success of his innovative research in bacterial biology and protein homeostasis.

Teaching Experience ๐Ÿ‘จโ€๐Ÿซ

Dr. Xu has a strong track record in teaching and academic supervision. From 2015 to 2020, he taught various courses such as Medical Biology, Medical Genetics, and Medical Cell Biology at Henan University of Science and Technology. His teaching not only involved extensive classroom hours but also practical experimental courses, allowing students to gain hands-on experience in molecular biology techniques. Since 2024, Dr. Xu has been supervising Masterโ€™s students at the University Paul Sabatier in Toulouse, mentoring students on projects related to phage peptides and protein homeostasis in bacteria, ensuring the next generation of scientists is equipped with the necessary research skills.

Legacy and Future Contributions ๐ŸŒŸ

Dr. Xuโ€™s current and future research promises to continue his legacy of groundbreaking work in microbiology, particularly in the areas of bacterial toxin-antitoxin systems and translation control. As a postdoctoral fellow and researcher at LMGM, he is leading projects that could revolutionize our understanding of bacterial growth regulation, with direct applications in combating drug-resistant Mycobacterium tuberculosis. His ongoing research, mentorship, and commitment to expanding scientific knowledge will ensure that his contributions to the field of microbiology will continue to grow in impact and influence.

ย Top Noted Publications ๐Ÿ“–

Title: Inducible auto-phosphorylation regulates a widespread family of nucleotidyltransferase toxins

Authors: Tom J. Arrowsmith, Xibing Xu, Shangze, Ben Usher, Peter Stokes, Megan Guest, Agnieszka K. Bronowska, Pierre Genevaux, Tim R. Blower
Journal: Nature Communications
Year: 2024

Title: MenT nucleotidyltransferase toxins extend tRNA acceptor stems and can be inhibited by asymmetrical antitoxin binding

Authors: Xibing Xu, Ben Usher, C. Gutierrez, R. Barriot, T.J. Arrowsmith, X. Han, P. Redder, O. Neyrolles, T.R. Blower, P. Genevaux
Journal: Nature Communications
Year: 2023

Title: Substrate recognition and cryo-EM structure of the ribosome-bound TAC toxin of Mycobacterium tuberculosis

Authors: Moรฏse, Emmanuel Giudice, Xibing Xu, Hatice Akarsu, Patricia Bordes, Valรฉrie Guillet, Donna-Joe Bigot, Nawel Slama, Gaetano D’Urso, Sophie Chat et al.
Journal: Nature Communications
Year: 2022

Title: ClpXP-mediated Degradation of the TAC Antitoxin is Neutralized by the SecB-like Chaperone in Mycobacterium tuberculosis

Authors: Pauline Texier, Patricia Bordes, Jyotsna Nagpal, Ambre Julie Sala, Moise Mansour, Anne-Marie Cirinesi, Xibing Xu, David Andrew Dougan, Pierre Genevaux
Journal: Journal of Molecular Biology
Year: 2021

Title: The ubiquitin-like modification by ThiS and ThiF in Escherichia coli

Authors: Xibing Xu, Tao Wang, Yulong Niu, Ke Liang, Yi Yang
Journal: International Journal of Biological Macromolecules
Year: 2019

Title: BAH1 an E3 Ligase from Arabidopsis thaliana Stabilizes Heat Shock Factor ฯƒ32 of Escherichia coli by Interacting with DnaK/DnaJ Chaperone Team

Authors: Xibing Xu, Ke Liang, Yulong Niu, Yan Shen, Xuedong Wan, Haiyan Li, Yi Yang
Journal: Current Microbiology
Year: 2018

Bohong Chen | Bioinformatics analysis | Best Researcher Award

Mr. Bohong Chen | Bioinformatics analysis | Best Researcher Award

Mr. Bohong Chen at The First Affiliated Hospital of Xi’an Jiaotong University, China

๐Ÿ‘จโ€๐ŸŽ“Professional Profile

๐Ÿง‘โ€๐Ÿ”ฌ Summary

Mr. Bohong Chen is a talented researcher from The First Affiliated Hospital of Xi’an Jiaotong University, China, currently pursuing his PhD with a focus on tumor drug resistance mechanisms, specifically for breast cancer. His work integrates transcriptomics, single-cell bioinformatics, and Mendelian randomization to better understand the molecular foundations of disease. With a strong academic background and multiple published articles in high-impact journals, Mr. Chen is well-equipped to contribute to foundational biomedical research aimed at improving cancer treatment strategies.

๐Ÿ‘จโ€๐ŸŽ“ Education

Mr. Bohong Chen is currently pursuing a PhD at The First Affiliated Hospital of Xi’an Jiaotong University in China, where he focuses on exploring the mechanisms of tumor drug resistance, particularly for breast cancer. Prior to this, he earned his Masterโ€™s degree under the supervision of Wu Dapeng, equipping him with strong research skills in bioinformatics and molecular biology.

๐Ÿ† Academic Honors

Mr. Chen has received several prestigious academic honors, including a Second-Class Scholarship for two consecutive years and the title of “Excellent Graduate Student” for the 2021 academic year. Additionally, he serves as a reviewer for the SCI journal PLOS ONE, demonstrating his academic contributions.

๐Ÿ’ป Technical Skills

With expertise in bioinformatics, Mr. Chen is proficient in using R Language for transcriptomic and single-cell data analysis. His skills also include Mendelian randomization, a method he uses for genetic epidemiology and to explore causal relationships in disease mechanisms. These technical skills form the backbone of his innovative research in tumor drug resistance and other medical conditions.

๐Ÿ‘จโ€๐Ÿซ Teaching Experience

In addition to his research, Mr. Chen has demonstrated teaching abilities as a Master’s Supervisor under Wu Dapeng. He assists graduate students in their research and offers valuable guidance in bioinformatics and genomics.

๐Ÿ”ฌ Research Interests

Mr. Chenโ€™s research interests are primarily focused on understanding tumor drug resistance, especially in breast cancer. He is particularly interested in leveraging advanced bioinformatics techniques such as single-cell sequencing and machine learning to identify novel therapeutic targets. His goal is to provide more effective treatment strategies for cancer patients by exploring the molecular mechanisms behind drug resistance.